SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028934
Filing Date
2018-11-09
Accepted
2018-11-09 16:16:45
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eigr-10q_20180930.htm 10-Q 1563367
2 EX-10.1 eigr-ex101_482.htm EX-10.1 312832
3 EX-10.2 eigr-ex102_530.htm EX-10.2 138964
4 EX-10.3 eigr-ex103_531.htm EX-10.3 186031
5 EX-31.1 eigr-ex311_9.htm EX-31.1 16849
6 EX-31.2 eigr-ex312_6.htm EX-31.2 16910
7 EX-32.1 eigr-ex321_11.htm EX-32.1 5752
  Complete submission text file 0001564590-18-028934.txt   5911485

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT eigr-20180930.xml EX-101.INS 1140556
9 XBRL TAXONOMY EXTENSION SCHEMA eigr-20180930.xsd EX-101.SCH 39698
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eigr-20180930_cal.xml EX-101.CAL 36488
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eigr-20180930_def.xml EX-101.DEF 118579
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigr-20180930_lab.xml EX-101.LAB 284378
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigr-20180930_pre.xml EX-101.PRE 221997
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36183 | Film No.: 181173280
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1